Prevalence and risk factors of metabolic dysfunction‐associated steatotic liver disease in south Central Uganda: A cross‐sectional survey

Ähnliche Einträge

• Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease
  von: Nabil Noureddin, et al.
  Veröffentlicht: (2024)
• Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease
  von: Nobuharu Tamaki, et al.
  Veröffentlicht: (2024)
• The overlap with metabolic dysfunction‐associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis
  von: María Hernández‐Pérez, et al.
  Veröffentlicht: (2024)
• Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction‐associated steatotic liver disease
  von: Richie Manikat, et al.
  Veröffentlicht: (2024)
• Systematic review with meta‐analysis: Steatosis severity and subclinical atherosclerosis in metabolic dysfunction‐associated steatotic liver disease
  von: Mohamad Jamalinia, et al.
  Veröffentlicht: (2024)